This study explores the development of a non-enzymatic electrochemical glucose sensor based on poly(3-aminobenzoic acid) (P3ABA) combined with silver nanoparticles (AgNPs). Incorporating AgNPs into the P3ABA matrix enhances the sensor’s electrocatalytic properties, leading to a system with greater stability. Cyclic voltammetry and chronoamperometry were employed to evaluate the sensor’s performance, demonstrating a sensitivity of 50.71 µA mM−1 cm−2 and a limit of detection (LOD) of 0.2 µM. The sensor exhibited a linear response over a broad concentration range (1 to 16 mM), with a coefficient of determination (R2) of 0.998, indicating good reproducibility and precision. These results highlight the potential of the P3ABA/AgNP composite for glucose sensing applications, offering an extended linear range, allowing for the quantification of glucose concentrations from very low to significantly high levels, covering both physiological and pathological conditions.
Several clinical trials have substantiated the efficacy of the co-administration of statins like atorvastatin and fibrates. Without information currently available about the interaction between the two drugs, a pharmacokinetic study was conducted to investigate the effect when both drugs were co-administered. The purpose of this study was to investigate the pharmacokinetic profile of tablets containing atorvastatin 20 mg, or the combination of atorvastatin 20 mg with fenofibrate 160 mg administered to healthy Mexican volunteers. This was a randomized, two-period, two-sequence, crossover study; 36 eligible subjects aged between 20 to 50 years were included. Blood samples were collected up to 96 h after dosing, and pharmacokinetic parameters were obtained by non-compartmental analysis. Adverse events were evaluated based on subject interviews and physical examinations. Area under the concentration-time curve (AUC) and maximum plasma drug concentration (Cmax) were measured for atorvastatin as the reference and atorvastatin and fenofibrate as the test product for bioequivalence design. The estimation computed (90% confidence intervals) for atorvastatin and fenofibrate combination versus atorvastatin for Cmax, AUC0-t and AUC0-∞, were 102,09, 125,95 and 120,97% respectively. These results suggest that atorvastatin and fenofibrate have no relevant clinical-pharmacokinetic drug interaction.
4 May 2021 in Journal of Biomaterials Applications
The aim of this study was to characterize the morphological properties of amorphous silica nanoparticles (SiO2 NPs), their cytotoxicity and intracellular location within Human Osteoblasts (HOB). Additionally, SiO2 NPs were explored for their effectivity as carriers of CRTC3-siRNA on Human Preadipocytes (HPAd), and thus downregulate RGS2 gene expression. SiO2 NPs were synthesized using the method of Stöber at 45 °C, 56 °C, and 62 °C. These were characterized via TEM with EDS, Zeta Potential and FT-IR. Cytotoxicity was evaluated by XTT at three concentrations 50, 100 and 500 µg/mL; SiO2 NPs intracellular localization was observed through Confocal Laser Scanning Microscope. Delivering siRNA effectivity was measured by RT-qPCR. Morphology of SiO2 NPs was spherical with a range size from 64 to 119 nm; their surface charge was negative. Confocal images demonstrated that SiO2 NPs were located within cellular cytoplasm. At a SiO2 NPs concentration of 500 µg/mL HOB viability decreased, while at 50 µg/mL and 100 µg/mL cell viability was not affected regardless SiO2 NPs size. SiO2 NPs-CRTC3-siRNA are effective to down-regulate RGS2 gene expression in HPAd without cytotoxic effects. The developed SiO2 NPs-CRTC3-siRNA are a promising tool as a delivery vehicle to control obesity.
A geopolymer, derived from agricultural waste, was used as an efficient, sustainable, and low-cost adsorbent of methylene blue, a recurrent industrial dye contaminant. The geopolymer was synthesized via a standard alkali activation process using wheat husk ash calcinated at 1050 °C. Adsorption capabilities were evaluated through batch kinetic experiments. The removal efficiency was determined by ultraviolet–visible spectrophotometry, and the adsorption kinetics were fitted to various models. The geopolymer demonstrated a maximum adsorption capacity of 270.58 mg/g for methylene blue, achieving a removal efficiency of 85.20% under optimal conditions. Kinetic analysis confirmed that the adsorption process is best described by the pseudo-second-order model. This suggests that chemisorption, which involves chemical bonding or electron exchange between the dye and the negatively charged aluminosilicate structure of the geopolymer, is the rate-limiting mechanism. This demonstrates that geopolymers are effective and promising adsorbents, valorizing an agricultural waste stream into a functional material for the efficient treatment of dye-polluted wastewater. The competitive capacity and favorable chemisorption mechanism position the geopolymer as a promising material for the remediation of dye-contaminated industrial effluents.
Persistent endodontic infections are frequently associated with Enterococcus faecalis, a microorganism capable of penetrating dentinal tubules and surviving conventional disinfection procedures. This in vitro study evaluated the antimicrobial activity of Chihuahuan propolis against E. faecalis using planktonic and intratubular infection models. Propolis extract was tested at concentrations of 15, 35, and 70 mg/mL and compared with triple antibiotic paste (TAP) as a clinically relevant intracanal medicament. Antimicrobial efficacy was assessed by disk diffusion, minimum inhibitory concentration (MIC), colony-forming unit (CFU) reduction in infected dentinal tubules, and scanning electron microscopy (SEM). Chihuahuan propolis exhibited concentration-dependent antimicrobial activity, with a MIC of 17.5 mg/mL. In the intratubular model, propolis at 70 mg/mL achieved a CFU reduction comparable to TAP after seven days of application. SEM analysis confirmed a marked reduction of bacterial colonization within dentinal tubules. Within the limitations of this in vitro, monoespecies model, Chihuahuan propolis demonstrated antimicrobial efficacy against E. faecalis comparable to TAP, supporting its further investigation as a potential non-antibiotic intracanal medicament.